Management of joint replacement surgery with a von Willebrand factor product with a low FVIII content in von Willebrand disease patients

被引：0
|
作者：
Borel-Derlon, A. [1 ]
Federici, A. B. [2 ]
Goudemand, J. [3 ]
Roussel-Robert, V [4 ]
Chatelanaz, C. [6 ]
Henriet, C. [6 ]
Bridey, F. [6 ]
机构：
[1] Univ Hosp, Haemophilia Treatment Ctr, Caen, France
[2] Univ Milan, Bianchi Bonomi Haemophilia & Thrombosis Ctr, I-20122 Milan, Italy
[3] Univ Hosp Lille, Haemophilia Treatment Ctr, Lille, France
[4] Univ Hosp Paris Cochin, Haemophilia Treatment Ctr, Paris, France
[5] Haemophilia Treatment Ctr, Montpellier, France
[6] LFB, Les Ulis, France
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2011年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P-WE-469
引用
收藏
页码：668 / 668
页数：1
相关论文
共 50 条
  • [41] Von Willebrand Factor and von Willebrand disease: new approaches to diagnosis
    Ines Woods, Adriana
    Noemi Blanco, Alicia
    Catalina Kempfer, Ana
    Paiva, Juvenal
    Ines Bermejo, Emilse
    Sanchez Luceros, Analia
    Angela Lazzari, Maria
    ACTA BIOQUIMICA CLINICA LATINOAMERICANA, 2016, 50 (02): : 273 - 289
  • [42] von Willebrand factor propeptide and the phenotypic classification of von Willebrand disease
    Sanders, Yvonne V.
    Groeneveld, Dafna
    Meijer, Karina
    Fijnvandraat, Karin
    Cnossen, Marjon H.
    van der Bom, Johanna G.
    Coppens, M.
    de Meris, Joke
    Laros-van Gorkom, Britta A. P.
    Mauser-Bunschoten, Eveline P.
    Leebeek, Frank W. G.
    Eikenboom, Jeroen
    BLOOD, 2015, 125 (19) : 3006 - 3013
  • [43] von Willebrand factor: from cell biology to the clinical management of von Willebrand's disease
    Vischer, UM
    de Moerloose, P
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 1999, 30 (02) : 93 - 109
  • [44] von Willebrand factor alloantibodies in type 3 von Willebrand disease
    Kotnik, Barbara Faganel
    Strandberg, Karin
    Debeljak, Marusa
    Kitanovski, Lidija
    Jazbec, Janez
    Benedik-Dolnicar, Majda
    Bakija, Alenka Trampus
    BLOOD COAGULATION & FIBRINOLYSIS, 2020, 31 (01) : 77 - 79
  • [45] Von Willebrand factor contribution to pathophysiology outside of von Willebrand disease
    Mojiri, Anahita
    Alavi, Parnian
    Jahroudi, Nadia
    MICROCIRCULATION, 2019, 26 (04)
  • [46] Pharmacokinetic analysis of a von Willebrand factor/factor VIII (VWF/FVIII) concentrate in adults-and children with von Willebrand disease (VWD)
    Di Paola, Jorge
    Lethagen, Stephan
    Gill, Joan
    Mannucci, Pier
    Bemstein, Jonathan
    Nichols, William
    Friedman, Carl
    Knaub, Sigurd
    Bergman, Garrett
    BLOOD, 2007, 110 (11) : 637A - 637A
  • [47] The Course of von Willebrand Factor and Factor VIII Activity in Patients with von Willebrand Disease during Pregnancy
    Delbrueck, Christiane
    Miesbach, Wolfgang
    ACTA HAEMATOLOGICA, 2019, 142 (02) : 71 - 78
  • [48] PHARMACOKINETIC MODELING OF THE VON WILLEBRAND FACTOR - FACTOR VIII INTERACTION IN PERIOPERATIVE VON WILLEBRAND DISEASE PATIENTS
    Bukkems, L. H.
    Heijdra, J.
    de Jager, N.
    Hazendonk, H.
    Fijnvandraat, K.
    Meijer, K.
    Eikenboom, J.
    Laros-van Gorkom, B.
    Leebeek, F.
    Cnossen, M.
    Mathot, R.
    HAEMOPHILIA, 2021, 27 : 147 - 147
  • [49] Quantification of von Willebrand Factor and von Willebrand Factor Propeptide in Patients with End Stage Renal Disease
    Davis, Rachael
    Bansal, Vinod
    Litinas, Evangelos
    Rahman, Saudur
    Hoppensteadt, Debra
    Conway, Brooke
    Fareed, Jawed
    FASEB JOURNAL, 2010, 24
  • [50] Molecular assessment of FVIII binding site in von Willebrand factor gene in suspects patients of von Willebrand disease type 2N
    Damian, G. B.
    Santos, A.
    Di Migueli, Oliveira C.
    Siqueira, L.
    Prezoti, A.
    Di Paula, E.
    Bizzacchi, J.
    Ozelo, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 840 - 840
12345